1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. RADIOTHERAPY MARKET BY OFFERING
5.1. Introduction
5.2. Hardware
5.3. Software & Services
6. RADIOTHERAPY MARKET BY TYPE
6.1. Introduction
6.2. Internal Radiation Therapy
6.3. External Radiation Therapy
6.3.1. 3D-Conformal Radiation Therapy (3D-CRT)
6.3.2. Intensity-Modulated Radiation Therapy (IMRT)
6.3.3. Image Guided Radiotherapy (IGRT)
6.3.4. Others
7. RADIOTHERAPY MARKET BY APPLICATION
7.1. Introduction
7.2. Prostate Cancer
7.3. Breast Cancer
7.4. Lung Cancer
7.5. Head & Neck Cancer
7.6. Others
8. RADIOTHERAPY MARKET BY END-USER
8.1. Introduction
8.2. Hospital
8.3. Ambulatory Surgical Center
8.4. Others
9. RADIOTHERAPY MARKET BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. USA
9.2.2. Canada
9.2.3. Mexico
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Others
9.4. Europe
9.4.1. Germany
9.4.2. France
9.4.3. United Kingdom
9.4.4. Spain
9.4.5. Others
9.5. Middle East and Africa
9.5.1. Saudi Arabia
9.5.2. UAE
9.5.3. Israel
9.5.4. Others
9.6. Asia Pacific
9.6.1. China
9.6.2. India
9.6.3. Japan
9.6.4. South Korea
9.6.5. Indonesia
9.6.6. Thailand
9.6.7. Taiwan
9.6.8. Others
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Competitive Dashboard
11. COMPANY PROFILES
11.1. Elekta AB
11.2. Accuray Incorporated
11.3. Ion Beam Applications Group
11.4. Canon Medical Systems Corporation
11.5. Mirada Medical
11.6. Eckert & Ziegler
11.7. Siemens Healthineers
11.8. Mevion Medical Systems, Inc.
11.9. ALCEN (PMB)
11.10. CQ Medical
12. APPENDIX
12.1. Currency
12.2. Assumptions
12.3. Base and Forecast Years Timeline
12.4. Key benefits for the stakeholders
12.5. Research Methodology
12.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES